Literature, news and videos pertinent to
The Chris Commerford HER2 Targeted Therapies Program
- Promising treatment for deadly Glioblastoma being tested on humans at Ivy Brain Tumor Center
- Virus could treat brain tumors by boosting immune system
- Killing Cancer - CBS 60 Minutes
- Gene Sequencing Project Discovers Mutations Tied to High-Grade Gliomas in Young Children
- NIH approves high-priority research within BRAIN Initiative
- Agenus trial of brain cancer vaccine shows better survival rate
- Tiny capsule effectively kills cancer cells
- Researchers Successfully Destroy Brain Tumor Cells; Use Unique Combination of Diet and Radiation Therapy
- Life-Saving DNA Test Overlooked in Rise of Colon Cancer
powered by Surfing Waves
The Chris Commerford HER2 Targeted Therapies Program
is a vital part of ICAN's Cancer Patient Advocacy and Clinical Trials Program Advocacy Services.
Federal Tax I.D.: EIN 86-0818253